ADMA Biologics, Inc.
(NASDAQ : ADMA)

( )
ADMA PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc. -1.54%74.761.0%$1946.65m
AMGNAmgen, Inc. -2.76%202.731.3%$903.34m
REGNRegeneron Pharmaceuticals, Inc. 3.23%488.292.6%$833.80m
BIIBBiogen, Inc. 0.08%316.381.5%$759.21m
VRTXVertex Pharmaceuticals, Inc. 2.60%237.951.9%$588.30m
MRNAModerna, Inc. -1.74%29.950.0%$535.64m
ILMNIllumina, Inc. -1.13%273.123.5%$472.24m
ALXNAlexion Pharmaceuticals, Inc. 2.90%89.792.0%$286.04m
AAgilent Technologies, Inc. -1.50%71.581.6%$228.47m
EXASEXACT Sciences Corp. -0.74%58.0021.0%$194.38m
INCYIncyte Corp. 1.47%73.232.5%$176.59m
SGENSeattle Genetics, Inc. 0.08%115.386.1%$169.50m
BMRNBioMarin Pharmaceutical, Inc. 2.44%84.504.3%$166.37m
NVAXNovavax, Inc. -5.04%13.58114.7%$124.83m
ALNYAlnylam Pharmaceuticals, Inc. 0.02%108.858.7%$102.43m

Company Profile

ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in the manufacturing, marketing and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing, Plasma Collection Center, and Corporate. The ADMA BioManufacturing segment comprises of the immune globulin manufacturing and development operations. The Plasma Collection Center consists of source plasma collection facilities. The Corporate segment includes general and administrative overhead expenses. The company was founded by Adam S. Grossman and Jerrold B. Grossman on June 2, 2006 and is headquartered in Hackensack, NJ.